DNA repair and immune checkpoint blockade response
- 24 February 2022
- journal article
- research article
- Published by Elsevier in Cancer Genetics
- Vol. 264-265, 1-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation BurdenCell Reports Medicine, 2020
- Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1JAMA Oncology, 2019
- Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer TypesJAMA Oncology, 2019
- Tumor mutational load predicts survival after immunotherapy across multiple cancer typesNature Genetics, 2019
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitorsInternational Immunopharmacology, 2018
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasCell Reports, 2018
- Landscape of Microsatellite Instability Across 39 Cancer TypesJCO Precision Oncology, 2017
- AACR Project GENIE: Powering Precision Medicine through an International ConsortiumCancer Discovery, 2017
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsNature Medicine, 2017